ReviewAnnals of surgical oncology2022

Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study.

Nobuhiro Nakazawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.